COMMUNIQUÉS West-GlobeNewswire

New Peer-Reviewed Publication Highlights Evidence of Mother-to-Child-Transmission of Lyme Disease Bacteria During Pregnancy and Calls for Urgent Research
09/04/2026
New paper in Frontiers in Medicine reports results of meeting of international researchers at the Banbury Center of Cold Spring Harbor Laboratory PORTOLA VALLEY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme [...]
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09/04/2026
Strengthens three community health models spanning community‑embedded care, earlier intervention and data ‑ driven population health Scales program footprint from 11 countries to more than 30 by 2030, including across [...]
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
09/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 9 April 2026 – 7:00 AM CET Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Fagron, the leading global [...]
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
09/04/2026
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support antibiotic BAL2420 (LptA inhibitor) first-in-human clinical [...]
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development
09/04/2026
Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirement Amer Joseph joins Idorsia as EVP, Chief Medical Officer [...]
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
09/04/2026
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference Halle (Saale) / Munich, Germany, April 9 , 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage [...]
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09/04/2026
Strengthens three community health models spanning community ‑ embedded care, earlier intervention and data ‑ driven population health Scales program footprint from 11 countries to more than 30 by 2030, including across [...]
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026
09/04/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of [...]
Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
08/04/2026
BANNOCKBURN, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today [...]
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
08/04/2026
Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- AVITA [...]
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
08/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]
Vireo Growth Inc. Announces Acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company
09/04/2026
Transaction further strengthens the Company’s balance sheet with approximately US$110 million of combined cash and net working capital Consideration of 213 million shares at a deemed price of US$0.60 and 80 million [...]
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
08/04/2026
PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf [...]
Telix Strengthens Board with Additional Director Appointments
09/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, [...]
Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien's 25-Year Milestone April 11 in Sugar Land, Texas
08/04/2026
What does it mean to meet one of the world's few fully Awakened teachers? A free community event on April 11 invites everyone to meet and be awakened by two of the world's rarest living spiritual teachers and no [...]
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/04/2026
SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
08/04/2026
RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the closing of [...]
Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check
08/04/2026
A 2026 overview of Found Health's GLP-1 medication access model, free online insurance coverage check, disclosed pricing for Wegovy, Zepbound, Ozempic, and compounded semaglutide options, telehealth program structure, [...]
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
08/04/2026
• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers • On track to provide mid-2026 program update ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a [...]

Pages